ストックスクリーナーアプリを入手
8.65
1.93%
-0.17
アフターアワーズ：
8.54
-0.11
-1.27%
Kura Oncology Inc (KURA) 最新ニュース
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Kura Oncology reports inducement grants under Nasdaq listing rule - TipRanks
BTIG cuts Kura Oncology stock rating to Neutral - MSN
Kura/Kyowa Kirin’s Ziftomenib Scores In NPM1m AML, But Differentiation Is Key - News & Insights
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML - BioWorld Online
SG Americas Securities LLC Buys New Shares in Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies - Benzinga
Kura Oncology falls despite trial success; rival Syndax gains - Seeking Alpha
Kura Oncology stock target raised to $40 by H.C. Wainwright - MSN
Market Watch Highlights: Kura Oncology Inc (KURA) Ends on an Upturn Note at 9.05 - The Dwinnex
Kura Oncology price target raised to $36 from $34 at Wedbush - TipRanks
BTIG cuts Kura Oncology stock rating to Neutral By Investing.com - Investing.com South Africa
A new trading data show Kura Oncology Inc (KURA) is showing positive returns. - SETE News
Kura to take AML drug ziftomenib to regulators after mid-stage win - The Pharma Letter
Kura Oncology (NASDAQ:KURA) Shares Up 6.7%Here's Why - MarketBeat
Kura stock slides 7% following ziftomenib update (KURA:NASDAQ) - Seeking Alpha
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs - The Manila Times
Kura Oncology And Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial - Marketscreener.com
Major Clinical Success: AML Drug Breakthrough Shows Promise for Blood Cancer Patients - StockTitan
Analyzing Kura Oncology Inc (KURA) After Recent Trading Activity - Knox Daily
KURA overperforms with a 7.76 increase in share price - US Post News
Senior Director, Investor Relations - Built In
BIOTECHNOLOGY VALUE FUND L P Reduces Stake in Kura Oncology Inc - GuruFocus.com
Kura Oncology Inc (KURA) Shares Soar Above 1-Year High - The News Heater
SG Americas Securities LLC Takes $436,000 Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Insider Selling: Kura Oncology, Inc. (NASDAQ:KURA) SVP Sells 4,949 Shares of Stock - MarketBeat
Kathleen Ford Sells 1,817 Shares of Kura Oncology, Inc. (NASDAQ:KURA) Stock - MarketBeat
Moody Aldrich Partners LLC Raises Position in Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Insider Sells $39,058.81 in Stock - MarketBeat
Kura Oncology's chief legal officer sells $57,315 in stock - MSN
Kura Oncology COO Kathleen Ford sells $14,303 in stock - MSN
Kura Oncology's chief scientific officer sells $17,050 in stock - MSN
Kura Oncology's finance SVP sells shares worth $38,958 - MSN
Kura Oncology's finance SVP sells shares worth $38,958 By Investing.com - Investing.com Australia
Kura Oncology's chief scientific officer sells $17,050 in stock By Investing.com - Investing.com Australia
Kura Oncology COO Kathleen Ford sells $14,303 in stock By Investing.com - Investing.com Australia
Kura Oncology's chief legal officer sells $57,315 in stock By Investing.com - Investing.com South Africa
Kura Oncology chief commercial officer sells shares valued at $12,461 By Investing.com - Investing.com Australia
Kura Oncology's chief medical officer sells shares worth $39,068 By Investing.com - Investing.com Canada
Kura Oncology chief commercial officer sells shares valued at $12,461 - Investing.com India
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kura Oncology: Sentiment Is Too Negative (NASDAQ:KURA) - Seeking Alpha
1.03%
大文字化:
|
ボリューム (24 時間):